By Jeff Overley ( July 22, 2015, 7:09 PM EDT) -- Watson Laboratories Inc. on Wednesday moved to eliminate extra exclusivity granted recently for Amarin Pharmaceuticals Ireland Ltd.'s omega-3 drug Vascepa, appealing to the D.C. Circuit and asking for permission to take over litigation from the U.S. Food and Drug Administration....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.